Skip to main content
SpringerLink
Log in

Spastic paresis after 6-aminonicotinamide: Metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

In rats the application of 10 mg/kg 6-aminonicotinamide (6-AN) leads to an accumulation of 6-phosphogluconate, by inhibition of 6-phosphogluconate dehydrogenase in the pentose phosphate pathway, in the cells of the spinal cord. The accumulation reaches its maximum after 18–24 h. It seems that there exists a relationship between the accumulation of 6-phosphogluconate and the lesion of the neuroglia, which is found in electron microscopic studies. Symptoms of a spastic paresis only develop later when the spinal interneurones are destroyed as a consequence of the lesion of the neuroglia. The accumulation of 6-phosphogluconate almost exceeds the 400 fold of the norm. No considerable differences are found between the effects of a dose of 35 mg 6-AN/kg and one of 10 mg 6-AN/kg.

Free gluconate is identified enzymically in the cells of the spinal cords of the rats treated with 6-AN. The compound is very probably formed by dephosphorylation and diffuses into the blood.

6-Phosphogluconate is an inhibitor of the phosphoglucose isomerase. Its accumulation shifts the equilibrium towards glucose 6-phosphate. The lactate concentration decreases as compared with the untreated controls.

Muscular action potentials are recorded extracellularly with a concentric needle electrode from the musculus gastrocnemius of rats treated with 6-AN. First activations of the electromyograms are found 48 h after the application of 10 mg 6-AN/kg. The electrical activities increase during the time in which a progressive destruction of the interneurones occurs. The electromyogram displays a permanent state of excitation with high amplitudes and an increased frequency. The continuity and intensity of the increased activity recorded by the electromyograph is the most important pathological finding.

p-Chlorophenyl-GABA and, still more so, chlorpromazine cause temporary reduction of the excitation processes and an electromyogram nearly at rest. Under the same conditions, haloperidol is only slightly effective.

The symptoms developed by the chemical destruction of the interneurones of the spinal cord, with rigidity and spasticity of the hind limbs, are suitable for testing antispastic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bein, H. J.: Pharmakologische Differenzierung von Muskel-Relaxantien. In: Aspekte der Muskelspastik, hrsg. v. W. Birkmayer, pp. 76–82. Bern-Stuttgart-Wien: Huber 1972

    Google Scholar 

  • Briel, G., Neuhoff, V., Maier, M.: Microanalysis of amino acids and their determination in biological material using dansyl chloride. Hoppe-Seylers Z. physiol. Chem. 353, 540–553 (1972)

    Google Scholar 

  • Coper, H., Hadass, H., Lison, H.: Untersuchungen zum Mechanismus zentralnervöser Funktionsstörungen durch 6-Amino-nicotinamid. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 255, 96–106 (1966)

    Google Scholar 

  • Coper, H., Herken, H.: Schädigung des Zentralnervensystems durch Antimetaboliten des Nikotinsäureamids. Ein Beitrag zur Molekularpathologie der Pyridinnukleotide. Dtsch. med. Wschr. 88, 2025–2036 (1963)

    Google Scholar 

  • De Robertis, E., Gerschenfeld, H. M.: Submicroscopic morphology and function of glial cells. Int. Rev. Neurobiol. 3, 1–65 (1961)

    Google Scholar 

  • Eccles, J. C.: The physiology of synapses. Berlin-Göttingen-Heidelberg: Springer 1964

    Google Scholar 

  • Folbergrova, J., Lowry, O. H., Passonneau, J. V.: Changes in metabolites of the energy reserves in individual layers of mouse cerebral cortex and subjacent white matter during ischaemia and anaesthesia. J. Neurochem. 17, 1155–1162 (1970)

    Google Scholar 

  • Gelfan, S., Tarlov, I. M.: Interneurones and rigidity of spinal origin. J. Physiol. (Lond.) 146, 594–617 (1959)

    Google Scholar 

  • Geller, L. M., Cowen, D., Wolf, A.: Effect of the antimetabolite 6-aminonicotinamide on sound-induced seizures in mice. Exp. Neurol. 14, 86–98 (1966)

    Google Scholar 

  • Glowinski, J., Axelrod, J.: Effects of drugs on the disposition of H3-norepinephrine in the rat brain. Pharmacol. Rev. 18, 775–785 (1966)

    Google Scholar 

  • Goldberg, L. I., Yeh, B. K.: Specific block of dopamine receptors in the renal vascular bed by chlorpromazine. Abstr. 4th Intern. Congr. Pharmacol. Basel, p. 359 (1969)

  • Goldberg, N. D., Passonneau, J. V., Lowry, O. H.: Effects of changes in brain metabolism on the level of citric acid cycle intermediates. J. biol. Chem. 241, 3997–4003 (1966)

    Google Scholar 

  • Golgi, C.: Opera Omnia, Vol. 1, p. 40, Milanol U. Hoepli (1903)

    Google Scholar 

  • Granit, R.: Receptors and sensory perception. The aims, means and results of electrophysiological research on the process of reception. New Haven: Yale University Press 1955

    Google Scholar 

  • Henatsch, H.-D., Ingvar, D. H.: Chlorpromazin und Spastizität. Eine experimentelle elektrophysiologische Untersuchung. Arch. Psychiatr. Z. Neurol. 195, 77–93 (1956)

    Google Scholar 

  • Henn, F. A., Hamberger, A.: Glial cell function: Uptake of transmitter substances. Proc. nat. Acad. Sci. (Wash.) 68, 2686–2690 (1971)

    Google Scholar 

  • Herken, H., Keller, K., Kolbe, H., Lange, K.: Renal gluconate excretion after 6-aminonicotinamide. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 213–216 (1975)

    Google Scholar 

  • Herken, H., Keller, K., Kolbe, H., Lange, K., Schneider, H.: Experimentelle Myelopathie — Biochemische Grundlagen ihrer cellulären Pathogenese. Klin. Wschr. 51, 644–657 (1973)

    Google Scholar 

  • Herken, H., Lange, K., Kolbe, H., Keller, K.: Antimetabolic action on the pentose phosphate pathway in the central nervous system induced by 6-aminonicotinamide. In: Central Nervous System —Studies on metabolic regulation and function (E. Genazzani and H. Herken, eds.), pp. 41–54. Berlin-Heidelberg-New York: Springer 1974

    Google Scholar 

  • Herken, H., Senft, G., Zemisch, B.: Der Einfluß von 6-Aminonicotinsäureamid auf die Verteilung der Natrium- und Kaliumionen zwischen dem extra- und intracellulären Raum in der Leber und der Skeletmuskulatur. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 253, 364–371 (1966)

    Google Scholar 

  • Janssen, P. A. J.: The pharmacology of haloperidol. Int. J. Neuropsychiat. 3, S 10-S 18 (1967)

    Google Scholar 

  • Johnson, W. J., McColl, J. D.: 6-Aminonicotinamide, a potent nicotinamide antagonist. Science 122, 834 (1955)

    Google Scholar 

  • Keller, K., Kolbe, H., Lange, K., Herken, H.: Behaviour of the glycolytic system of rat brain and kidney in vivo after inhibition of the glucose phosphate isomerase. II. Substrate concentrations under the influence of ischaemia, 6-aminonicotinamide, and 2-deoxyglucose. Hoppe-Seylers Z. physiol. Chem. 353, 1389–1400 (1972)

    Google Scholar 

  • Krieglstein, J., Stock, R.: Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide. Naunyn-Schmiedeberg's Arch. Pharmacol. 290, 323–327 (1975)

    Google Scholar 

  • Lange, K., Kolbe, H., Keller, K., Herken, H.: Der Kohlenhydratstoffwechsel des Gehirns nach Blockade des Pentose-Phosphat-Weges durch 6-Aminonicotinsäureamid. Hoppe-Seylers Z. physiol. Chem. 351, 1241–1252 (1970)

    Google Scholar 

  • Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., Schulz, D. W.: Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J. biol. Chem. 239, 18–30 (1964)

    Google Scholar 

  • Lowry, O. H., Passonneau, J. V., Schulz, D. W., Rock, M. K.: The measurement of pyridine nucleotides by enzymatic cycling. J. biol. Chem. 236, 2746–2755 (1961)

    Google Scholar 

  • Mayman, C. I., Gatfield, P. D., Breckenridge, B. McL.: The glucose content of brain in anaesthesia. J. Neurochem. 11, 483–487 (1964)

    Google Scholar 

  • Meyer-Estorf, G.: Untersuchungen zur Pathogenese der experimentellen Myelopathie nach 6-Aminonicotinsäureamid. Inaugural-Diss., Med. Fachbereiche, Freie Univ. Berlin (1975)

  • Meyer-Estorf, G., Schulze, P. E., Herken, H.: Distribution of 3H-labelled 6-aminonicotinamide and accumulation of 6-phosphogluconate in the spinal cord. Naunyn-Schmiedeberg's Arch. Pharmacol. 276, 235–241 (1973)

    Google Scholar 

  • Monnier, M., Gangloff, H.: Rabbit brain research, Vol. 1. Amsterdam: Elsevier 1961

    Google Scholar 

  • Neuhoff, V., von der Haar, F., Schlimme E., Weise, M.: Zweidimensionale Chromatographie von Dansyl-Aminosäuren im pico-Mol-Bereich, angewandt zur direkten Charakterisierung von Transfer-Ribonucleinsäuren. Hoppe-Seylers Z. physiol. Chem. 350, 121–128 (1969)

    Google Scholar 

  • Nyberg-Hansen, R.: Functional organization of descending supraspinal fibre systems to the spinal cord. Anatomical observations and physiological correlations. Ergebn. Anat. Entwickl.-Gesch. 39, H. 2. Berlin-Heidelberg-New York: Springer 1966

    Google Scholar 

  • Ramon y Cajal, S.: Histologie du système nerveux de l'homme et des vertébrés. Paris: A. Maloine 1909/1911

    Google Scholar 

  • Redetzki, H. M., Alvarez-O'Bourke, F.: 6-Aminonicotinamide, a central nervous system depressant. J. Pharmacol. exp. Ther. 137, 173–178 (1962)

    Google Scholar 

  • Rexed, B.: Some aspects of the cytoarchitectonics and synaptology of the spinal cord. In: Organization of the spinal cord. Progress in brain research, Vol. 11, pp. 58–90. Amsterdam-London-New York: Elsevier Publ. Co., 1964

    Google Scholar 

  • Rossum, J. M. van: The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch. int. Pharmacodyn. 160, 492–494 (1966)

    Google Scholar 

  • Schildkraut, J. J., Schamberg, S. M., Breese, G. R., Kopin, I. J.: Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action. Amer. J. Psychiat. 124, 600–608 (1967)

    Google Scholar 

  • Schneider, H.: Schädigung der Formatio reticularis durch den Antimetaboliten 6-Aminonicotinamid. VIe Congrès internat. Neuropath., pp. 135–136. Paris: Masson 1970

    Google Scholar 

  • Schneider, H.: Elektronenmikroskopische Befunde bei selektiven Läsionen der spinalen grauen Substanz. Untersuchungen am Modell der 6-Aminonikotinamid-Intoxikation und der temporären Ischämie. Habilitationsschr., Fachber. Klin.-Theor. Med., Freie Univ. Berlin 1971

  • Schneider, H., Coper, H.: Morphologische Befunde am Zentralnervensystem nach Vergiftung mit Antimetaboliten des Nicotinamids (6-Aminonicotinsäureamid und 3-Acetylpyridin) und einem Chinolinderivat (5-Nitro-8-hydroxychinolin). Arch. Psychiat. Z. ges. Neurol. 211, 138–154 (1968)

    Google Scholar 

  • Sitt, R., Losert, W., Schultz, G., Kaess, H., Senft, G.: Der Einfluß von Insulin auf den Kaliumtransport in der Skeletmuskulatur. Naunyn-Schmiederbergs Arch. Pharmak. exp. Path. 255, 398–406 (1966)

    Google Scholar 

  • Spiller, J.: Das Aminosäuremuster der motorischen Vorderhornregion des Rattenrückenmarks unter Einfluß von 6-Aminonicotinsäureamid sowie Isolierung und Charakterisierung von Dansyl-Äthanolamin. Inaugural-Diss., Med. Fak. Georg-August-Univ. Göttingen 1975

  • Sternberg, S. S., Philips, F. S.: 6-Aminonicotinamide and acute degenerative changes in the central nervous system. Science 127, 644–646 (1958)

    Google Scholar 

  • Stille, G.: Arousalhemmung und Katalepsie bei Neuroleptica. Arzneimittel-Forsch. 16, 255–256 (1966)

    Google Scholar 

  • Willis, W. D., Jr.: The localization of functional groups of interneurones. In: UCLA Forum in Medical Sciences, No. 11, The Interneuron (M. A. B. Brazier, ed.), pp. 267–287. Berkeley-Los Angeles: University of California Press 1969

    Google Scholar 

  • Wolf, A., Cowen, D.: Pathological changes in the central nervous system produced by 6-aminonicotinamide. Bull. N. Y. Acad. Med. 35, 814–817 (1959)

    Google Scholar 

  • Yeh, B. K., McNay, J. L., Goldberg, L. I.: Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J. Pharmacol. exp. Ther. 168, 303–309 (1969)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut der Freien Universität Berlin, Thielallee 69/73, D-1000, Berlin 33

    H. Herken, G. Meyer-Estorf, K. Halbhübner & D. Loos

Authors
  1. H. Herken
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Meyer-Estorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Halbhübner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Loos
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a grant of the Deutsche Forschungsgemeinschaft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herken, H., Meyer-Estorf, G., Halbhübner, K. et al. Spastic paresis after 6-aminonicotinamide: Metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, 245–255 (1976). https://doi.org/10.1007/BF00507347

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00507347

Key words

Search

Navigation